Recently, renewed emphasis has been placed on the potential role of myocardial stress biomarkers, particularly NT-proBNP, in detecting T2DM individuals with early cardiac dysfunction and at the highest risk of HF progression [11, 25–27]. The gene discussed is NPPB; the disease is type 2 diabetes mellitus.